CFDE Data Portal | Search SLC35D3

	Label	Description
	SLC35D3 associations Collection (Entity type)	Associations for SLC35D3_associations
	SLC35D3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SLC35D3 Gene (Entity type)	ENSG00000182747 - solute carrier family 35 member D3
	GSE193351 ruxolitinib 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273 GSE216292 palbociclib 14 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273,GSE216292 14 V 1 PALBOCICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172458 0 V 1 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

SLC35D3 associations

Associations for SLC35D3_associations

SLC35D3 associations.tsv

A file from IDG as part of the Harmonizome project

SLC35D3

ENSG00000182747 - solute carrier family 35 member D3

GSE193351 ruxolitinib 1 v 2 human dn

A Gene Set from LINCS

GSE203362 0 V 1 ENZALUTAMIDE HUMAN DN

A Gene Set from LINCS

GSE216273 GSE216292 palbociclib 14 v 1 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 5 human up

A Gene Set from LINCS

GSE216273,GSE216292 14 V 1 PALBOCICLIB HUMAN DN

A Gene Set from LINCS

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE172458 0 V 1 CISPLATIN HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.